Evaxion Biotech SG&A Expense (Quarterly) Analysis

Evaxion Biotech AS (EVAX)

3.78 -0.13 (-3.32%) USD | NASDAQ | May 07, 16:00

3.75 -0.03 (-0.79%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	1.864M
September 30, 2023	2.932M
June 30, 2023	2.741M
March 31, 2023	2.542M
December 31, 2022	2.308M
September 30, 2022	2.015M
June 30, 2022	2.147M
March 31, 2022	1.595M
December 31, 2021	1.496M

Date	Value
September 30, 2021	1.495M
June 30, 2021	1.915M
March 31, 2021	1.282M
December 31, 2020	1.782M
September 30, 2020	1.719M
June 30, 2020	1.372M
March 31, 2020	0.781M
December 31, 2019	0.761M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.761M

Minimum

Dec 2019

2.932M

Maximum

Sep 2023

1.809M

Average

1.782M

Median

Dec 2020

SG&A Expense (Quarterly) Benchmarks